A type of personalized care known as precision medicine, and its subset, genomic medicine, is now the standard of care in Connecticut’s Hartford HealthCare Cancer Institute, UConn Health Center in Farmington, Connecticut Children’s Medical Center in Hartford and Smilow Cancer Center at Yale New Haven Health.
“Cancer therapy has become precision therapy,” says Dr. Roy Herbst, professor of medicinal oncology and pharmacology, and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital.